+4 9 (0) 60 7 4 487 6 0
standing the test of time

Epstein Barr Virus (EBV)

The Epstein-Barr virus (HHV 4) is the pathogen in infectious mononucleosis and is also implicated in lymphomas (including Burkitt lymphomy) and nasopharyngeal carcinomas.

EBV enters the body through the mucosa. It replicates in epithelial cells of the oropharynx or cervix and enter B lymphocytes, where it continues to replicate. This results in the clinical picture of mononucleosis (kissing disease or Pfeiffer disease), which is characterized by fever and a generalized but mainly cervical swelling of the lymph nodes, typically accompanied by tonsillitis, pharyngitis, and some cases of mild hepatic involvement. EBV infects only a narrow spectrum of hosts and replicates very slowly. It persists in a latent state in B lymphocytes and can lead to their immortalization and tumor transformation.

EBV is excreted in saliva and pharyngeal secretions and is transmitted by close contact ("kissing disease"). As with all herpesviruses the level of generalized contamination is high (80-90 % of the adult population is infected), with the process beginning in childhood and continuing throughout adolescence. In undeveloped countries the frequency of occurrence is - because of the hygienic situation - much higher and amounts with the under-3 years old children close to 100%. The majority of infections run an asymptomatic course.

Disease

Symptoms

Complications

Infectious mononucleosis
(Kissing disease or Pfeifer disease)

Pharyngitis
Headache
Fever
Exanthem
Swelling of the lymph nodes
Tonsillitis with a white coating
In some cases hepatic involvement

Meningitis
Encephalitis
Exanthem

Also Implicated in:

Burkitt lymphomy
Nasopharyngeal carcinomas
Several lymphoproliferative syndromes

Infections may be diagnosed by:

  • PCR
  • Serology: Determination of specific antibodies in the early phase of disease (VCA) resp. 6-8 weeks after infection (EBNA) based on the ELISA-technique.NovaLisaTM Epstein-Barr Virus (EBV-VCA bzw. EBNA) ELISA:

The NovaLisaTM Epstein-Barr Virus (EBV-VCA bzw. EBNA)

ELISA is intended for the qualitative determination of IgG-/IgM- class antibodies
against Epstein-Barr-viruses in human serum or plasma (citrate).

Antigens:

EBV-VCA IgG/IgM: synthetic p18 peptide of the Epstein-Barr virus
EBV-EBNA IgG: recombinant Epstein-Barr virus nuclear antigen type 1 (EBNA-1)

Interpretation of the test-results

Antibody - Profile

Stage of Infection

EA(D)
IgG

VCA
IgM

VCA
IgG

EBNA
IgG


-

-

-

-

EBV Negative

-

-

+

+

Retrograde infection

+/-

+

+/-

-

Primary infection (early phase)

+/-

+/-

+

+/-

Primary infection (transient phase)

+/-

-

+

+

Primary infection (reconvalescent phase)

+

+

+

+

Reactivated EBV-infection

Specific performance characteristics:


Intraassay

Interassay

Sensitivity

Specificity

n

Mean

CV%

n

Mean

CV%

EBV (VCA) IgG

10

1.56

2.9

15

1.55

4.3

100%

100%

EBV (VCA IgM

25

1.32

5.1

24

1.37

6.9

93.5%

96.3%

EBV (EBNA) IgG

12

2.80

2.0

26

2.76

2.4

98.5%

89.5%

Order information:

ELISA

Number of Determinations

Product Number

EBV-VCA IgG

96

EBVG150

EBV-VCA IgM

96

EBVM150

EBV-EBNA IgG

96

EBVG580